43 results
8-K
EX-4.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
by paying to the Holder, as described below, an amount of cash consideration equal to the Black Scholes Value (as defined below) of the remaining … (and in the same proportion), valued at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
424B5
MTNB
Matinas Biopharma Holdings Inc
4 Apr 24
Prospectus supplement for primary offering
4:15pm
to such event. In certain circumstances, the holder will have the right to receive the Black Scholes Value of the warrant calculated pursuant to a formula set
8-K
EX-99.1
e870mw3gh7 9p0opkan
8 Mar 22
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
6:30am
8-K
EX-99.1
hsvdx 0if9
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
8-K
89rdma
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
PRER14A
hcr72l6do9ld
23 Sep 19
Preliminary revised proxy
4:32pm